$5.14+0.05 (+0.88%)
EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally.
EDAP TMS S.A. in the Healthcare sector is trading at $5.14 with a market capitalization of $169M. Wall Street consensus targets $6.88 (4 analysts), implying a +33.6% move over the next 12 months. The stock is currently near its 52-week high of $5.24, remaining 49.6% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $17.81Mβ | $51.61Mβ | $16.28Mβ | $18.81Mβ | $14.27M |
| Gross Profit | $8.15Mβ | $21.86Mβ | $7.01Mβ | $8.00Mβ | $5.99M |
| Operating Income | -$7.37Mβ | -$17.98Mβ | -$5.78Mβ | -$6.76Mβ | -$6.31M |
| Net Income | -$9.08Mβ | -$22.41Mβ | -$5.88Mβ | -$6.57Mβ | -$7.44M |
EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company o...
European equities traded in the US as American depositary receipts were trending higher late Monday
European equities traded in the US as American depositary receipts rose late Thursday morning with t
European equities traded in the US as American depositary receipts were lower late Wednesday morning
European equities traded in the US as American depositary receipts started the week significantly hi
European equities traded in the US as American depositary receipts were trending higher late Friday